The loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity

Agonists for PPARα are used clinically to reduce triglyceridesand improve high-density lipoprotein(HDL) cholesterol levels in patients with hyperlipidemia. Whether the mechanism of PPARα activati...